NCT01525082 2024-02-06Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsStanford UniversityPhase 2 Completed20 enrolled 15 charts
NCT01056601 2017-12-28Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine TherapyMasonic Cancer Center, University of MinnesotaPhase 2 Terminated7 enrolled 8 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts